Historical record - last NADAC publication: 8/22/2018
Product Information
GLYBURID-METFORMIN 1.25-250 MG is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0529 per EA under NDC 68382065301. Its NADAC has been published 103 times since Sep 21, 2016.
Strength
1.25; 250 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382065301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/22/2018
Active Ingredients
GLYBURIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206748On Market Since
4/7/2016
Pharmacological Classes
Price Statistics
The NADAC for GLYBURID-METFORMIN 1.25-250 MG has been published 103 times since Sep 21, 2016, and over the history we have for it it has declined 40.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0529 per EA |
|---|---|
| All-time high | $0.0883 (Oct 12, 2016) |
| All-time low | $0.0461 (Nov 22, 2017) |
| Median price | $0.0577 |
| Average price | $0.0548 |
| Largest weekly change | -30.0% (Oct 19, 2016) |
| Weeks tracked | 103 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the glyburide and metformin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GLYBURID-METFORMIN 1.25-250 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURID-METFORMIN 1.25-250 MG, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0529 per EA (NDC 68382065301), effective Sep 5, 2018.
How has the price of GLYBURID-METFORMIN 1.25-250 MG changed over time?
Over the history we have for it, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has declined 40.1%. It has been tracked across 103 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for GLYBURID-METFORMIN 1.25-250 MG?
Since Sep 21, 2016, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has ranged from a low of $0.0461 (Nov 22, 2017) to a high of $0.0883 (Oct 12, 2016), with a median of $0.0577 per EA.
Are there cheaper alternatives to GLYBURID-METFORMIN 1.25-250 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GLYBURID-METFORMIN 1.25-250 MG, so no direct lower-cost alternative is listed.
Who manufactures GLYBURID-METFORMIN 1.25-250 MG?
GLYBURID-METFORMIN 1.25-250 MG (NDC 68382065301) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification